South San Francisco, CA February 16, 2021 Press Release As South San Francisco begins construction of the Library, Parks and Recreation Center/Council Chambers on the city’s new Community Civic Campus, Genentech and Amgen Inc. recently announced donations totaling $3.5 million…
Tag: Genentech
Genentech Announces Full FDA Approval for Venclexta Combinations for Acute Myeloid Leukemia
South San Francisco, CA October 17, 2020 Genentech Press Release Approval supported by data from Phase III confirmatory trials, VIALE-A and VIALE-C VIALE-A study showed Venclexta plus azacitidine significantly improved overall survival in newly diagnosed AML compared to azacitidine alone…
Letter to Editor: Old Town Residents Need OUR Input at Planning Commission Meeting Thurs Oct 15th
South San Francisco, CA October 12, 2020 by a native South City Resident Please attend the Planning Commission Meeting Thursday, Oct 15, 2020 07:00 PM Pacific Time (US and Canada) Join Zoom Meeting CLICK HERE Meeting ID: 882 3138 0027…
FDA Approves Genentech’s Gavreto for Treatment of Adults With Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
South San Francisco, CA September 4, 2020 Submitted by Genentech Genentech Announces FDA Approval of Gavreto (pralsetinib) for the Treatment of Adults With Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer Gavreto is a once-daily, oral precision therapy that selectively inhibits…
Genentech and the Genentech Foundation Commit $42 Million to Address Immediate and Long-Term Effects of the COVID-19 Pandemic
South San Francisco, CA May 12, 2020 Press Release Genentech and the Genentech Foundation are announcing charitable commitments of $42 million to help address the devastating impact of the COVID-19 pandemic. This support includes emergency response grants as well as…
Genentech COVID-19 Update
South San Francisco, CA March 11,2020 Submitted by Heather Gloe, Genentech Corporate RelationsGen Genentech takes the health and safety of our employees, their families and our local communities very seriously, and we are actively responding to the COVID-19 public health…
Letter to Editor: Reminder: City Council vote tomorrow, Wednesday, November 13th 7 p.m., MSB 33 Arroyo
South San Francisco, CA November 12, 2019 by SSFResidents4SmartGrowth.com Reminder: The City Council will be voting on the PUC site development tomorrow evening, Wednesday, November 13th at 7:00 p.m. at the Municipal Services Building, 33 Arroyo. Your attendance is vital…
FDA Accepts Genentech’s Biologics License Application for Satralizumab for Neuromyelitis Optica Spectrum Disorder
South San Francisco, CA October 30, 2019 Press Release — Satralizumab represents a potential new approach to treating neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating disease often misdiagnosed as multiple sclerosis (MS) — SOUTH SAN FRANCISCO, CA — October…
SSFUSD Receives $2 Million Grant from Genentech in Support of Science Education
South San Francisco, CA October 1, 2019 Submitted by Peter Feng, PIO, SSFUSD South San Francisco Unified School District has received a $2 million grant from biotechnology company Genentech to support the rollout of a new science curriculum across the…
Genentech Presents Data from Studies in Spinal Muscular Atrophy at the 2019 AAN Annual Meeting
South San Francisco, CA May 7, 2019 Genentech Press Release Genentech Presents Data from the Risdiplam Pivotal FIREFISH and SUNFISH Studies in Spinal Muscular Atrophy at the 2019 AAN Annual Meeting In the dose-finding Part 1 of FIREFISH, infants with…